                                                                                                                                          0                1
                                                                             The CHMP confirmed eligibility to the centralised procedure on 12 November 2020
                                                                               The ETF recommended to start the rolling review procedure on 18 December 2020
The applicant submitted documentation as part of a rolling review on \nnon-clinical data to support the marketing authorisation application  29 January 2021
                                                                                                The procedure (Rolling Review 1) started on  1 February 2021
                                            The Rapporteur's first Assessment Report was circulated to all CHMP, \nPeer Reviewer and ETF on     1 March 2021
                                        The Rapporteurs circulated updated Joint Assessment reports to all \nCHMP, Peer Reviewer and ETF on     8 March 2021
                                                                                                              ETF discussions took place on     9 March 2021
                                             Adoption of first Interim Opinion (Rolling Review 1 [non-clinical]) via \nwritten procedure on    12 March 2021
     The applicant submitted documentation as part of a rolling review on \nquality data to support the marketing authorisation application    31 March 2021
                                                                                                The procedure (Rolling Review 2) started on     1 April 2021
                                       The Rapporteur's first Assessment Report was circulated to all CHMP, \nBWP, Peer Reviewer and ETF on    30 April 2021
                                                                                                              BWP discussions took place on       5 May 2021
                                        The Rapporteurs circulated updated Joint Assessment reports to all \nCHMP, Peer Reviewer and ETF on       6 May 2021
                                                                                                              ETF discussions took place on       7 May 2021